SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Indications - Neurodegenerative
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: pgo-neil who wrote (353)5/2/2010 1:25:15 PM
From: idos  Read Replies (1) of 448
 
The 20 subjects were NOT all randomly chosen, it was a retrospective genetic analysis comparing future multiple sclerosis patients (the study looked at genetic signature of subjects who were all healthy at the time their blood was taken) and age matched controls who remain healthy. The findings of this study are not related to the previously noted twin sequencing study that didn't find a genetic clue to MS. As a geneticist, my point of view is that everything is in the genome. Negative results usually mean we are still missing something big there. Many levels of control and many type of cells to look at but also environmental causes such as viruses are likely.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News